Cargando…
EIF1A depletion restrains human pituitary adenoma progression
EIF1A encodes a translation initiation factor in eukaryocyte and aberrant expression of EIF1A is deemed to be associated with dysfunctions in intracranial diseases. The goal of this research was to explore the impacts of EIF1A on progression of human pituitary adenoma (PA). We employed immunohistoch...
Autores principales: | Geng, Rongxin, Zhu, Xiaonan, Tao, Xiang, Liu, Junhui, Xu, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640735/ https://www.ncbi.nlm.nih.gov/pubmed/34864402 http://dx.doi.org/10.1016/j.tranon.2021.101299 |
Ejemplares similares
-
Gasdermin D Is a Novel Prognostic Biomarker and Relates to TMZ Response in Glioblastoma
por: Liu, Junhui, et al.
Publicado: (2021) -
Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas
por: Liu, Junhui, et al.
Publicado: (2022) -
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020) -
Human Pituitary Adenoma Proteomics: New Progresses and Perspectives
por: Zhan, Xianquan, et al.
Publicado: (2016) -
Progress in the Diagnosis and Classification of Pituitary Adenomas
por: Syro, Luis V., et al.
Publicado: (2015)